- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Garuda Therapeutics Inc.
Headquarters: Cambridge, MA, United States of America
Website: https://garudatx.com/
Year Founded: 2021
Status: Private
BioCentury | Mar 7, 2025
Finance
Strategics back Trimtech’s protein cluster degraders with $31M: Finance Report
Pharma venture arms join founding investors CIC, DDF to back U.K. start-up; plus venture rounds for Garuda, Ataraxis and Callio, and Tenaya’s follow-on
BioCentury | Mar 4, 2025
Management Tracks
Head of R&D Robert Lenz to leave Neumora
Plus: Jeffrey Sevigny named CMO of Rapport, and updates from Garuda, Metis, Ovid and more
BioCentury | Oct 25, 2023
Management Tracks
Korro promoting Chappell to COO, adding Pearson to board
Plus: 3T hires Irving and updates from Q32 Bio, Garuda and Fibrocor
BioCentury | Jul 13, 2023
Management Tracks
Howard Horn named CFO at Ultragenyx
Plus: Elizabeth Carpenter joins PhRMA, and updates from Garuda, SIRPant and Brainstorm
BioCentury | Feb 7, 2023
Deals
Feb. 7 Quick Takes: Garuda advancing stem cell program with $62M series B
Plus: Evonetix tops off series B and updates from Aldeyra, Neuron23, Slingshot and more
BioCentury | Sep 7, 2022
Management Tracks
Harpoon’s McMahon becomes CEO at Storm
Plus new CFO, CSO at Voyager and updates from Sonoma, Garuda, Alloy, Homology and more
BioCentury | Mar 16, 2022
Management Tracks
Lilly veteran Smiley to join Zai as COO
Plus Dias becomes CMO at Coherus, updates from Illumina, Metagenomi, Adrenomed, Epizyme, Garuda and more
BioCentury | Sep 24, 2021
Product Development
Sept. 23 Quick Takes: $72M series A for stem cell newco Garuda
Plus: On deck at ODAC, GenEdit, Worg-Apitope, Reata, Tyvyt and more
Items per page:
1 - 8 of 8